A phantom to assess the accuracy of tumor delineation using MRSI

Radiology and Oncology

Volumn 42, Issue 4, 2008, Pages 232-239

  Heikal, Amr A ^a,b   Wachowicz, Keith ^c   Thomas, Steven D ^c   Fallone, Biagio Gino ^c  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NONE

Author keywords

3 T; Brain; MR spectroscopic imaging; Phantoms; Tumor

Indexed keywords

GELATIN; WATER;

ACCURACY; ARTICLE; CLINICAL ASSESSMENT; FILTRATION; GEOMETRY; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 58149166421     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-008-0015-3     Document Type: Article

References (19)

1. Pallud J, Devaux B, Nataf F, Roux FX, Daumas-Duport C. Spatial delimitation of low grade oligodendrogliomas. Neurochirurgie 2005; 51: 253-9.
2. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004; 59: 126-37.
3. Walecki J, Tarasow E, Kubas B, Czemicki Z, Lewko J, Podgorski J, et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol 2003; 10: 145-53.
4. Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S, et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 2006; 33: 32-40.
5. McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 2001; 13: 167-77.
6. Hunjan S, Adalsteinsson E, Kim DH, Harsh GR, Boyer AL, Spielman D, et al. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data. Int J Radiat Oncol Biol Phys 2003; 57: 1159-73.
7. Woo DC, Kim BS, Jung SL, Park HJ, Rhim HS, Jahng GH, et al. Develpment of a cone-shaped phantom for multi-voxel MR scpectroscopy. J Neurosci Methods 2007; 162: 101-7.
8. 1H MRS head phantom. Med Phys 1998; 25: 1145-56.
9. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45: 765-9.
10. Drost DJ, Riddle WR, Clarke GD. Proton magnetic resonance spectroscopy in the brain: Report of AAPM Task Group #9. Med Phys 2002; 29: 2177-97.
11. Nishimura DG. Principles of magnetic resonance imaging: Stanford: Stanford University; 1996.
12. Haacke EM. Magnetic resonance imaging, physics principles and sequence design. New York: John Wiley & Sons; 1999.
13. Doddrell DM, Galloway G, Brooks W, Filed J, Bulsing J, Irving M, et al. Water signal elimination in vivo, using suppression by mistimed echo and repetitive gradient episodes. J Magn Reson 1986; 70: 176-80.
14. Hasse A, Frahm J, Hanicke W, Mattaei W. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30: 341-4.
15. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001; 14: 247-59.
16. Moré JJ. The Levenberg-Marquardt algorithm: implementation and theory. In: GA Watson, editor. Lecture notes in mathematics. Heidelberg: Springer Verlag; 1977. p. 105-16.
17. Nelson SJ, Graves E, Pirzkall A, Li X, Chan AA, Vigneron DB, et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002; 16: 464-76.
18. Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 2007; 80: 347- 54.
19. Jeun SS, Kim MC, Kim BS, Lee JM, Chung ST, Oh CH, et al. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy. J Clin Imaging 2005; 29: 10-5.